The tumor microenvironment modulation market is poised for growth driven by increasing focus on advanced immunotherapies, tumor biology understanding, and combination cancer treatments. Expansion is ...
Optical interconnects, leveraging intrinsic advantages such as high bandwidth, low loss, and immunity to electromagnetic interference (EMI), are thus regarded as a promising solution to these barriers ...
Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...
Newron Pharmaceuticals provides update following Type A meeting with the US FDA: Milan, Italy Saturday, July 4, 2026, 10:00 Hrs [IST] Newron Pharmaceuticals S.p.A. (Newron), a bio ...
Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
Akai Professional has launched the MPC One G2 and MPC Key 37 G2, both running an 8-core processor with 4GB RAM and 64GB internal storage for four times the processing power of their predecessors Both ...
A new approach for identifying signs of hidden awareness in people who cannot speak or move after severe brain injury has ...
Findings provide mechanistic support for previously reported clinical outcomes of clinical reversal of platinum resistance/refractoriness from ...
The Universitat Autònoma de Barcelona (UAB) and the Institute of Microelectronics of Barcelona (IMB-CNM-CSIC) have developed a new generation of wireless piezoelectric microdevices capable of ...
Alzheimer's disease (AD) is a devastating neurodegenerative disorder heavily characterized by amyloid-beta (Aβ) plaques, ...
Immune checkpoint blockade (ICB) has reshaped the treatment landscape for advanced hepatocellular carcinoma (HCC), offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results